ANL 10.42 Decreased By ▼ -0.08 (-0.76%)
ASC 9.04 Decreased By ▼ -0.15 (-1.63%)
ASL 11.07 Decreased By ▼ -0.06 (-0.54%)
AVN 77.00 Increased By ▲ 0.65 (0.85%)
BOP 5.42 Decreased By ▼ -0.02 (-0.37%)
CNERGY 5.25 Decreased By ▼ -0.02 (-0.38%)
FFL 6.59 Increased By ▲ 0.02 (0.3%)
FNEL 5.83 Decreased By ▼ -0.07 (-1.19%)
GGGL 11.04 Decreased By ▼ -0.04 (-0.36%)
GGL 16.45 Increased By ▲ 0.01 (0.06%)
GTECH 8.74 Increased By ▲ 0.22 (2.58%)
HUMNL 6.85 Decreased By ▼ -0.04 (-0.58%)
KEL 2.85 Decreased By ▼ -0.05 (-1.72%)
KOSM 3.19 Decreased By ▼ -0.01 (-0.31%)
MLCF 26.75 Decreased By ▼ -0.16 (-0.59%)
PACE 3.00 No Change ▼ 0.00 (0%)
PIBTL 6.00 Increased By ▲ 0.09 (1.52%)
PRL 17.04 Increased By ▲ 0.15 (0.89%)
PTC 6.98 Increased By ▲ 0.01 (0.14%)
SILK 1.18 Increased By ▲ 0.01 (0.85%)
SNGP 36.35 Increased By ▲ 0.05 (0.14%)
TELE 10.76 Increased By ▲ 0.17 (1.61%)
TPL 9.08 Decreased By ▼ -0.05 (-0.55%)
TPLP 20.10 Increased By ▲ 0.19 (0.95%)
TREET 28.70 Increased By ▲ 0.10 (0.35%)
TRG 76.75 Increased By ▲ 0.45 (0.59%)
UNITY 19.90 Increased By ▲ 0.05 (0.25%)
WAVES 12.70 Increased By ▲ 0.04 (0.32%)
WTL 1.36 No Change ▼ 0.00 (0%)
YOUW 5.09 Increased By ▲ 0.02 (0.39%)
BR100 4,075 Decreased By -15.7 (-0.38%)
BR30 14,980 Increased By 27.4 (0.18%)
KSE100 41,259 Decreased By -88.9 (-0.21%)
KSE30 15,704 Decreased By -33 (-0.21%)
World

Oxford University, AstraZeneca begin advanced trials of coronavirus vaccine

As part of the procedure, the trial will expand the age range of testing to children from 5 to 12 years old and adu
22 May, 2020
  • As part of the procedure, the trial will expand the age range of testing to children from 5 to 12 years old and adults 56 and older.
  • Adults will be randomly chosen to receive one or two doses of an already licensed vaccine against meningococcus for comparison.
  • AstraZeneca has agreed to initially supply at least 400 million doses of the vaccine and secured total manufacturing capacity to produce 1 billion doses.

(Karachi) The Oxford University and AstraZeneca Pls, a British-Swedish drugmaker, have started the process of recruiting more than 10,000 people for advanced human studies to conduct experiments on Covid-19 vaccines, Bloomberg reported.

As part of the procedure, the trial will expand the age range of testing to children from 5 to 12 years old and adults 56 and older. The other, larger stage will test the vaccine’s effectiveness in volunteers 18 and older.

https://twitter.com/business/status/1263750966429523969

Recently, AstraZeneca received funding worth 1.2 billion dollars from United States for its efforts to get the immunization tested and ready for use.

Adults will be randomly chosen to receive one or two doses of an already licensed vaccine against meningococcus for comparison.

Comments

Comments are closed.